Table 2 Profile of the enrolled patients
From: Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study
M/F | Age (years old) | BMI | Duration of HD (months) | Serum Alb (g/dL) | Serum ChE (IU/L) | Serum Cr (mg/dL) | Serum CRP (mg/dL) | Serum ALP (IU/L) | Hb (g/dL) | |
|---|---|---|---|---|---|---|---|---|---|---|
All | 93/126 | 55.1±10.8 | 22.7±4.1 | 74.5±61.8 | 3.48±0.41 | 230.8±68.6 | 2.08±1.89 | 0.33±0.69 | 247.2±126.3 | 11.48±1.71 |
Non-dialysis | 44/67 | 52.3±11.9* | 23.4±5.0† | 3.71±0.32* | 265.8±72.5* | 2.08±1.89 | 0.21±0.39‡ | 240.6±116.5 | 12.22±1.72* | |
Dialysis | 49/59 | 57.9±8.7* | 21.9±2.4† | 74.5±61.8 | 3.23±0.34* | 201.2±48.6* | 0.45±0.88‡ | 253.9±135.9 | 10.72±1.34* | |
No. of patients with ascites (/patients available abdominal image data) | Liver volume (cm 3 ) | Kidney volume (cm 3 ) | Total liver and kidney volume (cm 3 ) | No. of patients with cardiovascular disease | No. of patients with cerebrovascular disease | No. of patients with cancer | No of patients with mental disease | No of patients with diabetes | ||
31/176 | 3573.1±3088.7 | 3908.6±2578.3 | 7457.2±3801.6 | 21 | 21 | 11 | 5 | 2 | ||
10/72 | 3841.2±3550.9 | 3308.1±2566.2* | 7073.6±4175.2‡ | 8 | 13 | 7 | 4 | 2 | ||
21/104 | 3378.2±2620.3 | 4538.2±2487.9* | 7935.1±3393.5‡ | 13 | 8 | 4 | 1 | 0 | ||